NL7312270A - - Google Patents

Info

Publication number
NL7312270A
NL7312270A NL7312270A NL7312270A NL7312270A NL 7312270 A NL7312270 A NL 7312270A NL 7312270 A NL7312270 A NL 7312270A NL 7312270 A NL7312270 A NL 7312270A NL 7312270 A NL7312270 A NL 7312270A
Authority
NL
Netherlands
Application number
NL7312270A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7312270A publication Critical patent/NL7312270A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL7312270A 1972-09-08 1973-09-06 NL7312270A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US287423A US3862190A (en) 1972-09-08 1972-09-08 5-(unsubstituted and substituted phenoxy)-4-amino pyrimidines

Publications (1)

Publication Number Publication Date
NL7312270A true NL7312270A (cg-RX-API-DMAC7.html) 1974-03-12

Family

ID=23102839

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7312270A NL7312270A (cg-RX-API-DMAC7.html) 1972-09-08 1973-09-06

Country Status (13)

Country Link
US (1) US3862190A (cg-RX-API-DMAC7.html)
JP (1) JPS5543463B2 (cg-RX-API-DMAC7.html)
AR (1) AR202106A1 (cg-RX-API-DMAC7.html)
AU (1) AU471279B2 (cg-RX-API-DMAC7.html)
BE (1) BE804414A (cg-RX-API-DMAC7.html)
CA (1) CA996116A (cg-RX-API-DMAC7.html)
CH (1) CH581121A5 (cg-RX-API-DMAC7.html)
DE (1) DE2344611A1 (cg-RX-API-DMAC7.html)
ES (1) ES418567A1 (cg-RX-API-DMAC7.html)
FI (1) FI59796C (cg-RX-API-DMAC7.html)
FR (1) FR2198753B1 (cg-RX-API-DMAC7.html)
GB (1) GB1434805A (cg-RX-API-DMAC7.html)
NL (1) NL7312270A (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941889A (en) * 1972-09-08 1976-03-02 Pfizer Inc. 5-(Substituted phenoxy)-4-amino pyrimidines as anti-ulcer agents
JPS57164686U (cg-RX-API-DMAC7.html) * 1981-04-11 1982-10-16
JPS6197973U (cg-RX-API-DMAC7.html) * 1984-12-03 1986-06-23
JPS63135868U (cg-RX-API-DMAC7.html) * 1987-02-26 1988-09-06
WO1998014430A1 (en) * 1996-10-02 1998-04-09 Sumitomo Pharmaceuticals Co., Ltd. Pyrimidine derivatives
US6440965B1 (en) 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
US6583148B1 (en) * 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
WO2002008205A1 (en) * 2000-07-24 2002-01-31 Krenitsky Pharmaceuticals, Inc. Substituted 5-alkynyl pyrimidines having neurotrophic activity
PH12013501239A1 (en) 2010-12-24 2018-01-17 Nihon Nohyaku Co Ltd Benzyloxypyrimidine derivative, agricultural/horticultural insecticide comprising derivative and method for using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB886693A (en) * 1959-03-04 1962-01-10 Ici Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
FI59796B (fi) 1981-06-30
AU471279B2 (en) 1976-04-15
FR2198753B1 (cg-RX-API-DMAC7.html) 1976-09-03
FR2198753A1 (cg-RX-API-DMAC7.html) 1974-04-05
DE2344611A1 (de) 1974-03-14
CH581121A5 (cg-RX-API-DMAC7.html) 1976-10-29
US3862190A (en) 1975-01-21
GB1434805A (en) 1976-05-05
AU6003173A (en) 1975-03-06
BE804414A (fr) 1974-03-04
JPS5543463B2 (cg-RX-API-DMAC7.html) 1980-11-06
JPS4992080A (cg-RX-API-DMAC7.html) 1974-09-03
ES418567A1 (es) 1976-08-01
AR202106A1 (es) 1975-05-15
FI59796C (fi) 1981-10-12
CA996116A (en) 1976-08-31

Similar Documents

Publication Publication Date Title
FR2184752A1 (cg-RX-API-DMAC7.html)
JPS4991568A (cg-RX-API-DMAC7.html)
FR2181371A5 (cg-RX-API-DMAC7.html)
FR2198753B1 (cg-RX-API-DMAC7.html)
JPS48104414A (cg-RX-API-DMAC7.html)
JPS532091B2 (cg-RX-API-DMAC7.html)
JPS4958927A (cg-RX-API-DMAC7.html)
JPS494606A (cg-RX-API-DMAC7.html)
JPS5043304Y2 (cg-RX-API-DMAC7.html)
JPS5110988B2 (cg-RX-API-DMAC7.html)
JPS4981382A (cg-RX-API-DMAC7.html)
JPS4986455U (cg-RX-API-DMAC7.html)
JPS534263Y2 (cg-RX-API-DMAC7.html)
JPS4957320A (cg-RX-API-DMAC7.html)
JPS4915216U (cg-RX-API-DMAC7.html)
CH583094A5 (cg-RX-API-DMAC7.html)
CH574951A5 (cg-RX-API-DMAC7.html)
CH565891A (cg-RX-API-DMAC7.html)
SE7204350L (cg-RX-API-DMAC7.html)
DD97651A1 (cg-RX-API-DMAC7.html)
CH587847A5 (cg-RX-API-DMAC7.html)
CH582727A5 (cg-RX-API-DMAC7.html)
CH582640A5 (cg-RX-API-DMAC7.html)
CH582570A5 (cg-RX-API-DMAC7.html)
CH582516A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed